| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 26, 2021New No Fingerstick1 Sensor Integrates with Both the MiniMed 780G System and the Smart InPen System
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Mark for expanded functionality of the company's InPen™ smart2 insulin pen for...
-
Apr 14, 2021
Medtronic plc (NYSE: MDT), the global leader in medical technology, today introduced in select European countries the Medtronic Extended infusion set — the first and only infusion set that can...
-
Apr 7, 2021New Partnerships and Research Efforts Prioritized Over the Next Three Years to Address Health Disparities
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its ongoing commitment to health equity for people of color living with diabetes. The company committed...
-
Nov 12, 2020Real-Time Glucose Data Coupled with InPen's Dose Calculator Helps Users Make Better Dosing Decisions
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the launch of InPen™ integrated with real-time1 Guardian Connect™ CGM data. InPen is the first and only...
-
Sep 1, 2020New Smartphone Connected Hybrid Closed Loop System Will Be Available to Individuals as Young as 2
DUBLIN – September 1, 2020 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its...
